Detection of Chlamydia pneumoniae-reactive T lymphocytes in human atherosclerotic plaques of carotid artery

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 4, 2000, Pages 1061-1067

  Mosorin, Martti ^a   Surcel, Heljä Marja ^b   Laurila, Aino ^b   Lehtinen, Matti ^d   Karttunen, Riitta ^c   Juvonen, Jukka ^e   Paavonen, Jorma ^d   Morrison, Richard P ^f   Saikku, Pekka ^b   Juvonen, Tatu ^a  

^a OULU UNIVERSITY HOSPITAL   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c UNIVERSITY OF OULU   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

^e KAINUU CENTRAL HOSPITAL   (Finland)

^f MONTANA STATE UNIVERSITY   (United States)

Author keywords

Activated T cells; Atherosclerosis; Chlamydia pneumoniae

Indexed keywords

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; BACTERIUM DETECTION; CAROTID ARTERY DISEASE; CAROTID ENDARTERECTOMY; CELL PROLIFERATION; CHLAMYDOPHILA PNEUMONIAE; CLINICAL ARTICLE; ENDOTHELIUM CELL; HUMAN; IMMUNOHISTOLOGY; IN SITU HYBRIDIZATION; INFLAMMATORY INFILTRATE; MALE; MEMORY CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; RECEPTOR BINDING; T LYMPHOCYTE ACTIVATION;

EID: 0034032487     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.4.1061     Document Type: Article

References (29)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
2. Hansson GK, Holm J, Jonasson L. Detection of activated T lymphocytes in the human atherosclerotic plaque. Am J Pathol. 1989;135:169-175.
3. Stemme S, Hansson GK. Immune mechanisms in atherogenesis. Ann Med. 1994;26:141-146.
4. de Boer OJ, Hirsch F, van der Wal A, van der Loos CM, Das PK, Becker AE. Costimulatory molecules in human atherosclerotic plaques: an indication of antigen specific T lymphocyte activation. Atherosclerosis. 1997; 133:227-234.
5. Saikku P. Chlamydia pneumoniae and atherosclerosis: an update. Scand J Infect Dis. 1997;104:53-56.
6. Campbell LA, Kuo CC, Grayston JT. Chlamydia pneumoniae and cardiovascular disease. Emerg Infect Dis. 1998;4:571-579.
7. Moazed TC, Kuo C-C, Grayston JT, Campbell LA. Evidence of systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse. J Infect Dis. 1998;177:1322-1325.
8. Airenne S, Surcel H-M, Alakärppä H, Laitinen K, Paavonen J, Saikku P, Laurila A. Chlamydia pneumoniae infection in human monocytes. Infect Immun. 1999;67:1445-1449.
9. Kol A, Sukhova GK, Lichtman AH, Libby P. Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-α and matrix metalloproteinase expression. Circulation. 1998;98:300-307.
10. Halme S, Saikku P, Surcel H-M. Characterization of Chlamydia pneumoniae antigens using human T cell clones. Scand J Immunol. 1997;45: 378-384.
11. Lehtinen M, Lähdeaho M-L, Parkkonen P, Hyöty H, Mäki M, Paavonen J. Evolutionary conserved and species specific B-cell epitopes in chlamydial 60 kDa GroEL-like stress protein HybB. In: Mårdh P-A, La Placa M, Ward M, eds. Proceedings of the 2nd European Society for Chlamydial Research; University of Uppsala; Uppsala, Sweden: 1992:73-76.
12. Alakärppä H, Surcel H-M, Laitinen K, Juvonen T, Saikku P, Laurila A. Detection of Chlamydia pneumoniae by colorimetric in situ hybridization. APMIS. 1999;107:451-454.
13. Surcel H-M, Syrjälä H, Leinonen M, Saikku P, Herva E. Cell-mediated immunity to Chlamydia pneumoniae measured as lymphocyte blast transformation in vitro. Infect Immun. 1993;61:2196-2199.
14. Reece JC, Geysen HM, Rodda SJ. Mapping the major human T helper epitopes of tetanus toxin. J Immunol. 1993;151:6175-6184.
15. Lehtinen M, Hibma MH, Stellato G, Nieminen P, Paavonen J. T helper cell epitopes overlap B cell and putative cytotoxic T cell epitopes in the E2 protein of human papilloma virus type 16. Biochem Biophys Res Commun. 1995;25:541-546.
16. Halme S, Juvonen T, Laurila A, Juvonen J, Mosorin M, Saikku P, Surcel H-M. Chlamydia pneumoniae reactive T lymphocytes in the walls of abdominal aortic aneurysms. Eur J Clin Invest. 1999;29:546-552.
17. Muhlestein JB, Hammond EH, Carlquist JF, Radicke E, Thomson MJ, Karagounis LA, Woods ML, Anderson JL. Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. J Am Coll Cardiol. 1996;27:1555-1561.
18. Kuo C-C, Shor C-C, Campbell LA, Fukushi H, Patton DL, Grayston JT. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis. 1993;167:841-849.
19. Campbell LA, O'Brien ER, Cappuccio AL, Kuo CC, Wang SP, Stewart D, Patton DL, Cummings PK, Grayson JT. Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. J Infect Dis. 1995;172:585-588.
20. Stemme S, Faber B, Holm J, Wiklund O, Witztum JL, Hansson GK. T lymphocytes from human atherosclerotic plaques recognize oxidized low-density lipoprotein. Proc Natl Acad Sci U S A. 1995;92:3893-3897.
21. Xu Q, Willeit J, Marosi M, Kleindienst R, Oberhollenzer F, Kiechl S, Stulnig T, Luef G, Wick G. Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis. Lancet. 1993;341: 255-259.
22. Schett G, Metzler B, Mayr M, Amberger A, Niederwieser D, Gupta RS, Mizzen L, Xu Q, Wick G. Macrophage-lysis mediated by autoantibodies to heat shock protein 65/60. Atherosclerosis. 1997;128:27-38.
23. Xu Q, Dietrich H, Steiner HJ, Gown AM, Schoel B, Mikuz G, Kaufmann SHA, Wick G. Induction of arteriosclerosis in normocholesterolemic rabbits by immunization with heat shock protein65. Arterioscler Thromb. 1992;12:789-799.
24. Beatty WL, Byrne GI, Morrison RP. Repeated and persistent infection with Chlamydia and the development of chronic inflammation and disease. Trends Microbiol. 1994;2:94-98.
25. Yi Y, Yang X, Brunham RC. Autoimmunity to heat shock protein 60 and antigen-specific production of interleukin-10. Infect Immun. 1997;65: 1669-1674.
26. Metzler B, Schett G, Kleindienst R, van der Zee, Ottenhoff T, Hajeer A, Bernstein R, Xu Q, Wick G. Epitope specificity of anti-heat shock protein 65/60 serum antibodies in atherosclerosis. Arterioscler Thromb Vasc Biol. 1997;17:536-541.
27. Sinigaglia F, Hammer J. Motifs and supermotifs for MHC class II binding peptides. J Exp Med. 1995;181:449-451.
28. Ettinger RA, Kwok WW. A peptide binding motif for HLA-DQA1*0102/ DQB1*0602, the class II MHC molecule associated with dominant protection in insulin-dependent diabetes mellitus. J Immunol. 1998;160: 2365-2373.
29. Rothbard JB, Taylor WR. A sequence pattern common to T cell epitopes. EMBO J. 1988;7:93-100.